Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Monday its dividend for the second quarter of 2022.
The company has declared dividend of USD0.98 per share on outstanding common stock.
The dividend will be paid to shareholders of record at 16 May 2022 on 10 June 2022.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government